Poseida Therapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of P-PSMA-101 Autologous CAR-T for Metastatic Castration-Resistant Prostate Cancer by Seini Moimoi | May 20, 2020 | Portfolio News
Tricida Announces Proposed Offering of $175 Million Convertible Senior Notes Due 2027 by Seini Moimoi | May 19, 2020 | Portfolio News
Axonics® ARTISAN Results Published Demonstrating Continued Therapy Response and Patient Satisfaction at 1-year by Seini Moimoi | May 19, 2020 | Portfolio News
Akebia Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares by Seini Moimoi | May 19, 2020 | Portfolio News
National Burden of Macrolide-Resistant Streptococcus Pneumoniae in the United States From Blood and Respiratory Tract Cultures Approaches 40 Percent by Seini Moimoi | May 18, 2020 | Portfolio News
